New quality measures for organ transplantation finalized

CMS finalized a rule that revamps quality reporting measures with the goal of boosting transparency in the organ procurement and transplantation process, according to the agency.

The rule updates the Organ Procurement Organization Conditions for Coverage needed to be reimbursed by Medicare and Medicaid. The final rule is designed to help the more than 100,000 people in the U.S. on a waiting list for a lifesaving organ transplant, according to CMS.

The rule creates two new objective measures designed to increase incentives to use all available organs and to actually transplant them. One measures the number of organs an OPO has gotten from eligible donors in its donation service area. The other measures the rate of transplantation as opposed to procurement of the organs alone. The previous measures created a disincentive to go after all available organs.

Also under the new rules, underperforming OPOs will compete for their contracts and the worst performers will be unable to renew their contracts, the CMS said in a release. There are 58 OPOs in the U.S., each with its own designated area.

“Thousands of Americans are languishing on organ waitlists, and twenty Americans every day die waiting for an organ,” said CMS Administrator Seema Verma, in the release. “This is unacceptable,” she said.



Source link

Blog article

Healthcare’s supply chain poses the next big environmental challenge

Healthcare companies in recent years have largely focused on reducing greenhouse gas emissions as they strive to become more environmentally sustainable. While that focus has produced several innovations in conservation and alternative energy use, critics argue those actions have only scratched the surface of reducing healthcare’s climate footprint. Hospitals have remained one of the world’s […]

Read More
Blog article

Cerner to lay off 150 workers next month

New Cerner CEO Dr. David Feinberg on Thursday told employees that a set of layoffs will take place in November, a company spokesperson confirmed to Modern Healthcare. Feinberg, who took the helm as Cerner’s CEO on Oct. 1 following nearly three years leading Google Health, sent an email to employees Thursday evening after noticing a […]

Read More
Blog article

Expert panel takes up complicated COVID-19 booster questions

Influential government advisers are deciding Thursday how best to expand the nation’s COVID-19 booster campaign, including whether and when it’s OK to “mix and match” brands for the extra dose. The advisers to the Centers for Disease Control and Prevention are slated to discuss who should get extra doses of the Moderna or Johnson & […]

Read More